Brief: Enveric Biosciences Receives Notice Of Allowance From USPTO For C4-Carboxylic Acid-Substituted Tryptamine Derivatives For Next Generation Psilocin Prodrug
24/05/2023 13:27
May 24 (Reuters) - Enveric Biosciences Inc ENVB.O :
* ENVERIC BIOSCIENCES RECEIVES NOTICE OF ALLOWANCE FROM
USPTO FOR
C4-CARBOXYLIC ACID-SUBSTITUTED TRYPTAMINE DERIVATIVES FOR NEXT
GENERATION PSILOCIN PRODRUG
Source text for Eikon: ID:nBw5lbqwra
Further company coverage: ENVB.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Enveric Biosciences
See all newsBrief: Enveric Biosciences Announces Positive Results From IND-Enabling ADMET Studies
Enveric Biosciences Q2 net loss widens
AtaiBeckley surges after report Lilly poised to buy psychedelic drug developer
Brief: Enveric Biosciences Initiates Investigational New Drug (IND)-Enabling Genotoxicity Studies Of Lead Neuroplastogen Candidate EB-003
Brief: Enveric Biosciences Reports Positive Preclinical Results From Phototoxicity Analysis For Lead Neuroplastogen Candidate Eb-003